Avoiding Axillary Sentinel Lymph Node Biopsy after Neoadjuvant Systemic Therapy in Breast Cancer: Rationale for the Prospective, Multicentric EUBREAST-01 Trial

SIMPLE SUMMARY: Improvements in systemic treatments for breast cancer have increased the rates of pathologic complete response (pCR) in patients receiving preoperative systemic therapy (PST), offering the opportunity to de-escalate, and perhaps eliminate, surgery in patients who have a pCR. We propo...

Descripción completa

Detalles Bibliográficos
Autores principales: Reimer, Toralf, Glass, Aenne, Botteri, Edoardo, Loibl, Sibylle, D. Gentilini, Oreste
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763449/
https://www.ncbi.nlm.nih.gov/pubmed/33317077
http://dx.doi.org/10.3390/cancers12123698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763449/
https://www.ncbi.nlm.nih.gov/pubmed/33317077
http://dx.doi.org/10.3390/cancers12123698

Ejemplares similares